Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years
- PMID: 9195509
Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years
Abstract
Objective: Prognosis studies have indicated that survival of patients with systemic lupus erythematosus (SLE) has improved significantly. We investigate whether the apparent improvement in the survival of patients with SLE is associated with a reduction in the risk of death compared with the general population, or with changes over time in the distribution of various prognostic factors.
Methods: The University of Toronto cohort of 720 patients with SLE followed between 1970 and 1994 was divided into 3 groups based on year of entry into study: Group A 1970-77, Group B 1978-85, Group C 1986-1994. Standardized mortality ratios (SMR) were calculated for each cohort. Prognostic factors for death occurring in the first 8 yr period after entry into the study were examined in each of the 3 cohorts. Analysis involved chi-squared tests for categorical values and unpaired t tests for continuous variables.
Results: Group A comprised 183 patients, Group B 332 patients, and Group C 205 patients. An examination of the first 8 years of evaluation for each group revealed that the SMR decrease over time ranged from 10.1-fold greater than the general population in Group A, to 4.8-fold in Group B, to 3.3-fold in Group C. Prognostic factors for death varied over time, with vasculitis decreasing and hyperlipidemia increasing.
Conclusion: Survival in SLE has improved over 24 yrs in the University of Toronto cohort more than the health of the general population has improved. This improved survival was not related to changing demographics, severity of lupus at presentation, major change in disease patterns, or new modalities of treatment.
Similar articles
-
The effect of menopause on disease activity in systemic lupus erythematosus.J Rheumatol. 2006 Nov;33(11):2192-8. Epub 2006 Sep 15. J Rheumatol. 2006. PMID: 16981295
-
Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.J Rheumatol. 2004 Apr;31(4):713-9. J Rheumatol. 2004. PMID: 15088296
-
Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.J Rheumatol. 2000 Mar;27(3):685-91. J Rheumatol. 2000. PMID: 10743809
-
Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus.Autoimmun Rev. 2004 Aug;3(6):423-53. doi: 10.1016/j.autrev.2004.04.002. Autoimmun Rev. 2004. PMID: 15351310 Review.
-
Outcome and prognosis in systemic lupus erythematosus.Rheum Dis Clin North Am. 1988 Apr;14(1):67-78. Rheum Dis Clin North Am. 1988. PMID: 3041492 Review.
Cited by
-
Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up.Rheumatology (Oxford). 2022 Dec 23;62(1):200-208. doi: 10.1093/rheumatology/keac218. Rheumatology (Oxford). 2022. PMID: 35412595 Free PMC article.
-
Health service utilization among African American women living with systemic lupus erythematosus: perceived impacts of a self-management intervention.Arthritis Res Ther. 2019 Jun 25;21(1):155. doi: 10.1186/s13075-019-1942-7. Arthritis Res Ther. 2019. PMID: 31238992 Free PMC article. Clinical Trial.
-
Effect of low and high HDL-C levels on the prognosis of lupus nephritis patients: a prospective cohort study.Lipids Health Dis. 2017 Dec 6;16(1):232. doi: 10.1186/s12944-017-0622-3. Lipids Health Dis. 2017. PMID: 29212518 Free PMC article.
-
Impact of follow-up visits on disease outcome in Chinese systemic lupus erythematosus.Clin Rheumatol. 2018 Jan;37(1):101-105. doi: 10.1007/s10067-017-3781-8. Epub 2017 Aug 3. Clin Rheumatol. 2018. PMID: 28776301
-
Cardiac involvement in juvenile idiopathic arthritis.Rheumatol Int. 2017 Jan;37(1):137-142. doi: 10.1007/s00296-016-3534-z. Epub 2016 Jul 14. Rheumatol Int. 2017. PMID: 27417551 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical